(Q38629522)

4 September 2017

1 reference

title

Cardiovascular benefits of estrogen replacement therapy (English)

1 reference

4 September 2017

1 reference

4

Henderson BE

1 reference

4 September 2017

Ross RK

1

1 reference

4 September 2017

Paganini-Hill A

series ordinal

2

1 reference

4 September 2017

Mack TM

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 May 1989

1 reference

American Journal of Obstetrics and Gynecology

4 September 2017

1 reference

4 September 2017

160

1 reference

4 September 2017

1301-1306

1 reference

4 September 2017

5 Pt 2

1 reference

Menopause and coronary heart disease. The Framingham Study

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

A prospective study of postmenopausal estrogen therapy and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Myocardial infarction and estrogen therapy in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Noncontraceptive estrogens and nonfatal myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

The effects of long-term estrogen on hysterectomized women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Postmenopausal estrogen use and heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Estrogen use and cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Hormone-replacement therapy and heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Breast cancer and estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Exogenous estrogen and breast cancer after bilateral oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

The association of replacement estrogens with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Menopausal oestrogens and breast cancer risk: an expanded case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Menopausal estrogen use and the risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Replacement estrogens and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Estrogen use and breast cancer. Interaction with body mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Estrogen replacement therapy and protection from acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980017-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(89)80017-1

1 reference

4 September 2017

1 reference